Recently, there has been an increasing trend in the adoption of lung stereotactic body radiation therapy (SBRT) for early-stage NSCLC, and it has proved to be an appropriate treatment of choice for medically inoperable early-stage NSCLC with high local control rates and with low toxicity [ 15–22 ].
← all excerpts
Stereotactic body radiation therapy for early-stage non-small-cell lung cancer in octogenarians and older: an alternative treatment.
1
—
—